RBC Europe’s Thermo Fisher Scientific TMO Stock Holding History

RBC Europe’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$98.9M	Buy	182,038 +27,380	+18%	+$15.1M	4.76%	7
2022 Q1	$91.3M	Buy	154,658 +38,176	+33%	+$21.9M	3.72%	10
2021 Q4	$77.7M	Buy	116,482 +55,359	+91%	+$34.6M	3.42%	10
2021 Q3	$34.9M	Buy	61,123 +4,697	+8%	+$2.58M	1.43%	13
2021 Q2	$28.5M	Buy	56,426 +6,809	+14%	+$3.21M	1.29%	15
2021 Q1	$22.6M	Buy	49,617 +6,616	+15%	+$3.16M	1.22%	16
2020 Q4	$20M	Buy	43,001 +11,759	+38%	+$5.51M	1.15%	16
2020 Q3	$13.8M	Buy	31,242 +14,690	+89%	+$6.07M	0.92%	21
2020 Q2	$6M	Buy	16,552 +2,281	+16%	+$765K	0.46%	38
2020 Q1	$4.05M	Buy	14,271 +2,378	+20%	+$750K	0.4%	42
2019 Q4	$3.86M	Buy	11,893 +900	+8%	+$273K	0.34%	50
2019 Q3	$3.2M	Buy	10,993 +575	+6%	+$165K	0.32%	55
2019 Q2	$3.06M	Buy	10,418 +994	+11%	+$274K	0.31%	62
2019 Q1	$2.58M	Buy	9,424 +1,359	+17%	+$338K	0.28%	66
2018 Q4	$1.8M	Buy	8,065 +880	+12%	+$206K	0.24%	78
2018 Q3	$1.75M	Buy	7,185 +6,390	+804%	+$1.47M	0.19%	86
2018 Q2	$165K	Buy	795 +280	+54%	+$59.4K	0.02%	277
2018 Q1	$106K	Hold	515	–	–	0.01%	333
2017 Q4	$97.8K	Hold	515	–	–	0.01%	355
2017 Q3	$97.4K	Buy	+515	New	+$93.3K	0.01%	361

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBC Europe's TMO Position: Q2 2022 in Review

RBC Europe increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2022, buying an estimated $15.1M and bringing the position to 182,038 shares worth $98.9M. The position accounts for 4.76% of the portfolio, ranked #7.

RBC Europe first reported a position in TMO in Q3 2017 and has held it in 20 quarters since. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

RBC Europe held 182,038 shares of Thermo Fisher Scientific worth $98.9M as of Q2 2022.
RBC Europe bought 27,380 Thermo Fisher Scientific shares in Q2 2022, an estimated $15.1M.
Thermo Fisher Scientific made up 4.76% of RBC Europe's portfolio in Q2 2022, its #7 holding.
RBC Europe first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 20 quarters since.
2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.